Hyperfine (HYPR) Preferred Stock Liabilities (2020 - 2022)
Hyperfine's (HYPR) quarterly Preferred Stock Liabilities came in at $333.2 million in Q4 2022, up 3.3% YoY from $322.5 million in Q4 2021, and up 3.3% on a QoQ basis from $322.5 million in Q4 2021.
Hyperfine (HYPR) Preferred Stock Liabilities (2020 - 2022) Analysis & Trends
Hyperfine (HYPR) has 3 years of Preferred Stock Liabilities data on file, last reported at $333.2 million in Q4 2022.
- Quarterly Preferred Stock Liabilities rose 3.3% year-over-year to $333.2 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $333.2 million (up 3.3% YoY) and the FY2022 annual result came in at $333.2 million, up 3.3% from the prior year.
- Preferred Stock Liabilities rose to $333.2 million in Q4 2022, from $322.5 million in the prior quarter.
- In the past five years, Preferred Stock Liabilities ranged from a high of $333.2 million in Q4 2022 to a low of $10.9 million in Q1 2021.
- A 3-year average of $169.0 million and a median of $167.6 million in 2020 frame the typical range for Preferred Stock Liabilities.
- Annual changes were most pronounced in 2021 — Preferred Stock Liabilities jumped 151.42% — and 2022, when it gained 3.3%.
- Tracing HYPR's Preferred Stock Liabilities over 3 years: stood at $128.3 million in 2020, then surged by 151.42% to $322.5 million in 2021, then rose by 3.3% to $333.2 million in 2022.
- The last three Preferred Stock Liabilities figures came in at $333.2 million (Q4 2022), $322.5 million (Q4 2021), and $207.0 million (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Hyperfine | 89.83 Mn | 45.06 Mn | 1.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 333.20 Mn |
| Dec 31, 2021 | 322.54 Mn |
| Sep 30, 2021 | 207.00 Mn |
| Jun 30, 2021 | 12.35 Mn |
| Mar 31, 2021 | 10.92 Mn |
| Dec 31, 2020 | 128.29 Mn |